Our Chemiflex™ Critical Raw Materials Program allows you to customize all aspects of active pharmaceutical ingredient (API) synthesis for small molecule drug manufacture, from non-clinical through commercial phases. You can save time and prevent regulatory setbacks during scale-up with an assured source of high-quality raw materials, intermediates, and documentation – all available in quantities and qualities suitable for current good manufacturing practices (cGMP). Benefits include:
Small Molecule Drug Synthesis: Consideration for a Seamless Transition from Preclinical to Commercial Supply of Raw Materials
Transitioning Chemical Specialties from Clinical to Commercial in Small Molecule Drug Synthesis
In addition to a comprehensive raw materials portfolio, we also offer custom manufacturing services to meet your exact needs.
Our portfolio of critical raw materials is custom tailored to your application needs and regulatory requirements with assured quality and transparency.
Ensuring the compliance of pharma and biopharma products involves the compilation of a vast amount of data, which can be time- and resource-intensive. To accelerate this process, we developed our Emprove® Program. All solvents and reagents in the portfolio are complemented by dossiers designed to help you speed your way through the regulatory maze.
To continue reading please sign in or create an account.Don't Have An Account?